Petros Pharmaceuticals, Inc. (PTPI)
PTPI is quoted over the counter, not listed on an exchange. Petros Pharmaceuticals, Inc. files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.
Closes: Yahoo Finance daily closes, last bar 2026-11-16.
Profile
| Field | Value |
|---|---|
| Ticker | PTPI, quoted over the counter |
| SEC CIK | 0001815903 |
| OTC Markets tier | Pink (price source, 2026-11-13) |
| SEC industry code | Pharmaceutical Preparations |
| Business address | New York, NY |
| Incorporated in | DE |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | States substantial doubt about continuing as a going concern. "These conditions and events raise substantial doubt about the Company's ability to continue as a going concern within one year after the date that these unaudited condensed consolidated financial statements are issued." | 10-Q 2026-08-13 |
| Cash and burn | $3.5M cash; operating cash flow -$929K a quarter. | Report 2026-06-30 |
| Shares outstanding | 42,372,260 (2026-08-15); 42,372,260 a year earlier; 2,113,570 three years earlier. 3y figure adjusted for splits (1-for-25 overall). | Cover page 2026-08-15 |
| Reverse splits, 3 years | 1; latest 1-for-25 on 2025-05-01 | Source 2025-05-01 |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Delisting | 25-NSE filed | 25-NSE 2025-11-20 |
| Auditor | HTL International, LLC, Houston, Texas, United States; changed auditors 2 times in 24 months | 8-K 4.01 2025-09-05 |
| Late filings, 12 months | 1 NT notice | NT 10-K 2026-03-31 |
| Insider trades, 12 months | Bought $0, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q2 2026 2026-06-30 | Not filed | -$956K | -$864K | $3.5M | No debt tags | Needs four quarters | 10-Q 2026-08-13 |
| Q1 2026 2026-03-31 | Not filed | -$987K | -$784K | $4.4M | No debt tags | Needs four quarters | 10-Q 2026-05-13 |
| Q4 2025 2025-12-31 | Not filed | -$337K | -$934K | $5.1M | No debt tags | Needs four quarters | 10-K 2026-04-15 |
| Q3 2025 2025-09-30 | Not filed | -$923K | -$1.1M | $6.1M | No debt tags | Needs four quarters | 10-Q 2025-11-13 |
| Q2 2025 2025-06-30 | Not filed | $5.4M | -$3.0M | $7.3M | No debt tags | Needs four quarters | 10-Q 2026-08-13 |
| Q1 2025 2025-03-31 | Not filed | -$2.3M | -$1.7M | $8.9M | $7.2M | Needs four quarters | 10-Q 2026-05-13 |
| Q4 2024 2024-12-31 | $725K | -$9.3M | $965K | $1.7M | $14.4M | $5.1M | 10-K 2025-03-31 |
| Q3 2024 2024-09-30 | $1.6M | -$2.2M | -$771K | $3.9M | $2.3M | $4.0M | 10-Q 2024-11-13 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B4 | 2025-02-19 |
| Latest annual report | 10-K | 2026-04-15 |
| Latest quarterly / interim | 10-Q | 2026-08-13 |
| Latest current report | 8-K | 2026-09-30 |
| Latest proxy | DEF 14A | 2025-03-18 |
Source: SEC EDGAR submissions feed, 257 recent filings. All filings on EDGAR.
The full dossier has every filing, quarterly and annual financials, the health record and a price chart.
Open the full dossier